Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Suprachoroidal Space”

13 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 13 results

Not applicableUnknownNCT06154330
What this trial is testing

Safety and Efficacy of Suprachoroidal Tube Shunt in Patients With Primary Open and Pseudoexfoliation Glaucomas

Who this might be right for
Glaucoma, Open-AngleSuprachoroidal SpacePseudo Exfoliation Syndrome
Davinci LTD 91
Testing effectiveness (Phase 2)Active Not RecruitingNCT04514653
What this trial is testing

RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Neovascular Age-Related Macular Degeneration (nAMD)

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)
AbbVie 146
Not applicableStudy completedNCT05038072
What this trial is testing

The Use of Suprachoroidal Triamcinolone Acetonide to Treat Macular Edema in Retinal Vein Occlusion

Who this might be right for
Macular EdemaRetinal Vein Occlusion
Damascus University 16
Testing effectiveness (Phase 2)Study completedNCT01789320
What this trial is testing

Safety Study of Suprachoroidal Triamcinolone Acetonide Via Microneedle to Treat Uveitis

Who this might be right for
UveitisIntermediate UveitisPosterior Uveitis+2 more
Clearside Biomedical, Inc. 11
Not applicableActive Not RecruitingNCT05024695
What this trial is testing

Evaluate the Safety and Effectiveness of iSTAR Medical's MINIject™ Implant for Lowering Intraocular Pressure (IOP) in Subjects With Primary Open-angle Glaucoma.

Who this might be right for
Glaucoma
iSTAR Medical 975
Testing effectiveness (Phase 2)Study completedNCT05891548
What this trial is testing

Study to Evaluate Suprachoroidally Administered CLS-AX in the Treatment of Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Clearside Biomedical, Inc. 60
Not applicableEnrolling By InvitationNCT05296447
What this trial is testing

Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With Diabetic Retinopathy

Who this might be right for
Diabetic Retinopathy, DR
AbbVie 100
Testing effectiveness (Phase 2)Study completedNCT02255032
What this trial is testing

Suprachoroidal Injection of Triamcinolone Acetonide in Subjects With Macular Edema Following Non-Infectious Uveitis

Who this might be right for
UveitisMacular EdemaUveitis, Posterior+3 more
Clearside Biomedical, Inc. 22
Not applicableStudy completedNCT01461278
What this trial is testing

Multicenter Investigation of the Glaukos® Suprachoroidal Stent Model G3 In Conjunction With Cataract Surgery

Who this might be right for
Primary Open-angle Glaucoma
Glaukos Corporation 505
Testing effectiveness (Phase 2)Active Not RecruitingNCT04567550
What this trial is testing

RGX-314 Gene Therapy Administered in the Suprachoroidal Space for Participants With Diabetic Retinopathy (DR) With and Without Center Involved-Diabetic Macular Edema (CI-DME)

Who this might be right for
Diabetic Retinopathy (DR)Center-Involved Diabetic Macular Edema (CI-DME)
AbbVie 139
Not applicableLooking for participantsNCT06691555
What this trial is testing

Long-term Safety and Efficacy of a Modified Suprachoroidal Silicone Tube (SST) Shunt

Who this might be right for
GlaucomaOpen Angle Glaucoma (OAG)POAG+3 more
Davinci LTD 66
Not applicableEnrolling By InvitationNCT05210803
What this trial is testing

Long-Term Follow-Up Study of RGX-314 Administered in the Suprachoroidal Space for Participants With nAMD

Who this might be right for
Neovascular Age-Related Macular Degeneration (nAMD)Gene TherapyAMD+3 more
AbbVie 115
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06839339
What this trial is testing

Efficacy and Safety of AL-001 Ophthalmic Injection in Subjects with WAMD

Who this might be right for
Wet Age-related Macular Degeneration (wAMD)
Beijing Anlong Biopharmaceutical Co., Ltd. 40